| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Chongqing Xishan Science & Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥71.22 |
| 52 Week High | CN¥201.00 |
| 52 Week Low | CN¥67.55 |
| Beta | 0 |
| 1 Month Change | -2.16% |
| 3 Month Change | -5.46% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.75% |
Recent News & Updates
Shareholder Returns
| 688576 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.8% | 5.3% | 3.1% |
| 1Y | n/a | -13.9% | -13.1% |
Return vs Industry: Insufficient data to determine how 688576 performed against the CN Medical Equipment industry.
Return vs Market: Insufficient data to determine how 688576 performed against the CN Market.
Price Volatility
| 688576 volatility | |
|---|---|
| 688576 Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688576 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688576's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 619 | n/a | www.xishantech.com.cn |
Chongqing Xishan Science & Technology Co., Ltd. engages in the research and development, manufacture, sale, and service of digital minimally invasive surgical devices and medical consumables in China. It offers surgical power devices, endoscope systems, energy surgery equipment, and monitoring systems, as well as WFNS high speed drill sets, surgical staplers, and vacuum assisted breast biopsy and resection systems.
Chongqing Xishan Science & Technology Co., Ltd. Fundamentals Summary
| 688576 fundamental statistics | |
|---|---|
| Market cap | CN¥3.77b |
| Earnings (TTM) | CN¥119.28m |
| Revenue (TTM) | CN¥367.42m |
31.6x
P/E Ratio10.3x
P/S RatioIs 688576 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688576 income statement (TTM) | |
|---|---|
| Revenue | CN¥367.42m |
| Cost of Revenue | CN¥111.87m |
| Gross Profit | CN¥255.56m |
| Other Expenses | CN¥136.28m |
| Earnings | CN¥119.28m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.25 |
| Gross Margin | 69.55% |
| Net Profit Margin | 32.46% |
| Debt/Equity Ratio | 0% |
How did 688576 perform over the long term?
See historical performance and comparison